Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ocular Behçet Disease-Clinical Manifestations, Treatments and Outcomes According to Age at Disease Onset.
Ostrovsky M, Rosenblatt A, Iriqat S, Shteiwi A, Sharon Y, Kramer M, Vishnevskia-Dai V, Sar S, Boulos Y, Tomkins-Netzer O, Lavee N, Ben-Arie-Weintrob Y, Pizem H, Hareuveni-Blum T, Schneck M, Gepstein R, Masarwa D, Nakhoul N, Bakshi E, Shulman S, Goldstein M, Ramon D, Anouk M, Habot-Wilner Z. Ostrovsky M, et al. Among authors: iriqat s. Biomedicines. 2023 Feb 19;11(2):624. doi: 10.3390/biomedicines11020624. Biomedicines. 2023. PMID: 36831160 Free PMC article.
Current practice in the management of ocular toxoplasmosis.
Yogeswaran K, Furtado JM, Bodaghi B, Matthews JM; International Ocular Toxoplasmosis Study Group; Smith JR. Yogeswaran K, et al. Br J Ophthalmol. 2023 Jul;107(7):973-979. doi: 10.1136/bjophthalmol-2022-321091. Epub 2022 Feb 23. Br J Ophthalmol. 2023. PMID: 35197262
Retinal vascular occlusions in ocular Behçet disease - a comparative analysis.
Ostrovsky M, Ramon D, Iriqat S, Shteiwi A, Sharon Y, Kramer M, Vishnevskia-Dai V, Sar S, Boulos Y, Tomkins-Netzer O, Lavee N, Ben-Arie-Weintrob Y, Pizem H, Hareuveni-Blum T, Schneck M, Gepstein R, Masarwa D, Nakhoul N, Bakshi E, Shulman S, Goldstein M, Anouk M, Rosenblatt A, Habot-Wilner Z. Ostrovsky M, et al. Among authors: iriqat s. Acta Ophthalmol. 2023 Sep;101(6):619-626. doi: 10.1111/aos.15645. Epub 2023 Feb 7. Acta Ophthalmol. 2023. PMID: 36750991 Free article.
Ocular Inflammatory Events Following COVID-19 Vaccination in the Paediatric Population: A Multinational Case Series.
Testi I, Brandão-de-Resende C, De-La-Torre A, Concha-Del-Rio LE, Cheja-Kalb R, Mahendradas P, Habot-Wilner Z, Yalçındağ N, Markelj Š, Iriqat S, Portero A, Petrushkin H, Pavesio C, Solebo AL. Testi I, et al. Among authors: iriqat s. Ocul Immunol Inflamm. 2024 Sep;32(7):1237-1242. doi: 10.1080/09273948.2023.2220782. Epub 2023 Jun 14. Ocul Immunol Inflamm. 2024. PMID: 37315304
Blau syndrome: a case report from Palestine.
Iriqat S, Safieh MA, Fatouleh M, Alkaiyat A. Iriqat S, et al. Pediatr Rheumatol Online J. 2021 Aug 31;19(1):138. doi: 10.1186/s12969-021-00633-y. Pediatr Rheumatol Online J. 2021. PMID: 34465352 Free PMC article.
Use of immunomodulatory treatment for non-infectious uveitis: an International Ocular Inflammation Society report of real-world practice.
Branford JA, Bodaghi B, Ferreira LB, McCluskey PJ, Thorne JE, Matthews JM; International Study Group for Systemic Immunomodulatory Drug Treatment of Non‐Infectious Uveitis; Smith JR. Branford JA, et al. Br J Ophthalmol. 2024 Nov 1:bjo-2024-326239. doi: 10.1136/bjo-2024-326239. Online ahead of print. Br J Ophthalmol. 2024. PMID: 39472042
11 results